These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36578263)

  • 21. Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis.
    Daily JW; Kang S; Park S
    Biofactors; 2021 Mar; 47(2):218-231. PubMed ID: 33347668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?
    Megur A; Baltriukienė D; Bukelskienė V; Burokas A
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.
    Murray ER; Kemp M; Nguyen TT
    Arch Clin Neuropsychol; 2022 Feb; 37(3):595-607. PubMed ID: 35202456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary Pattern, Gut Microbiota, and Alzheimer's Disease.
    Zhang M; Zhao D; Zhou G; Li C
    J Agric Food Chem; 2020 Nov; 68(46):12800-12809. PubMed ID: 32090565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
    Cui B; Su D; Li W; She X; Zhang M; Wang R; Zhai Q
    J Neuroinflammation; 2018 Jun; 15(1):190. PubMed ID: 29933742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional effects of gut microbiota-derived metabolites in Alzheimer's disease.
    Choi H; Mook-Jung I
    Curr Opin Neurobiol; 2023 Aug; 81():102730. PubMed ID: 37236067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
    Shabbir U; Arshad MS; Sameen A; Oh DH
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interlink between the gut microbiota and inflammation in the context of oxidative stress in Alzheimer's disease progression.
    Das TK; Ganesh BP
    Gut Microbes; 2023; 15(1):2206504. PubMed ID: 37127846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Microbes to Memories: Challenges and Future Perspectives Regarding the Gut-Brain Axis for Improved Cognitive Health in Alzheimer's.
    Franco CD; Sagar RS; Bokhari SFH
    Cureus; 2024 Jan; 16(1):e52795. PubMed ID: 38389631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies.
    Seo DO; Holtzman DM
    Exp Mol Med; 2024 Feb; 56(1):86-94. PubMed ID: 38172602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Potential Role of Gut Microbiota in Alzheimer's Disease: From Diagnosis to Treatment.
    Varesi A; Pierella E; Romeo M; Piccini GB; Alfano C; Bjørklund G; Oppong A; Ricevuti G; Esposito C; Chirumbolo S; Pascale A
    Nutrients; 2022 Feb; 14(3):. PubMed ID: 35277027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer's Disease.
    Choi H; Lee D; Mook-Jung I
    J Alzheimers Dis; 2022; 86(4):1501-1526. PubMed ID: 35213369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS.
    Faulin TDES; Estadella D
    Arq Gastroenterol; 2023; 60(1):144-154. PubMed ID: 37194773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Clostridium butyricum against Microglia-Mediated Neuroinflammation in Alzheimer's Disease via Regulating Gut Microbiota and Metabolites Butyrate.
    Sun J; Xu J; Yang B; Chen K; Kong Y; Fang N; Gong T; Wang F; Ling Z; Liu J
    Mol Nutr Food Res; 2020 Jan; 64(2):e1900636. PubMed ID: 31835282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of the microbiota-gut-brain axis on Alzheimer's disease pathophysiology.
    Doifode T; Giridharan VV; Generoso JS; Bhatti G; Collodel A; Schulz PE; Forlenza OV; Barichello T
    Pharmacol Res; 2021 Feb; 164():105314. PubMed ID: 33246175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.